Home NDC 59762-1350-01 NDC 59762-1350-01 - Rifabutin This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 59762-1350
Requested NDC 59762-1350-01
Package NDCs from labels 59762-1350-1, 59762-1350-01
Manufacturer REMEDYREPACK INC.
Effective date 2026-09-01
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Rifabutin capsules, USP REMEDYREPACK INC. 2026-09-01 HUMAN PRESCRIPTION DRUG LABEL Rifabutin capsules, USP Mylan Pharmaceuticals Inc. | Pfizer Italia S.r.l. 2026-07-20 HUMAN PRESCRIPTION DRUG LABEL
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59762-1350-1 Rifabutin 100 in 1 BOTTLE CAPSULE 100 13
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59762-1350 RIFABUTIN CAPSULE [MYLAN PHARMACEUTICALS INC.] 12 Current NDC, Legacy NDC, 1 package rows 20250523_c2026b67-4755-4236-96b6-a6b5e7399707.zip
DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 135 · 2,696 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.